<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03388073</url>
  </required_header>
  <id_info>
    <org_study_id>NIS135002</org_study_id>
    <nct_id>NCT03388073</nct_id>
  </id_info>
  <brief_title>Evaluation of Plant-based Nutritional Products on Stem Cells</brief_title>
  <official_title>Evaluation of Plant-based Nutritional Products on Stem Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Natural Immune Systems Inc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Natural Immune Systems Inc</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical study is to evaluate acute effects of plant-based nutritional&#xD;
      extracts on adult stem cells, using a randomized double-blinded placebo-controlled cross-over&#xD;
      study design.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this clinical study is to evaluate acute effects of plant-based nutritional&#xD;
      extracts on adult stem cells, using a randomized double-blinded placebo-controlled cross-over&#xD;
      study design. The research involves testing of acute effects of single doses of&#xD;
      antioxidant-rich berry-based extracts, compared to a placebo. Blood samples are taken at&#xD;
      baseline and 1 and 2 hours after consuming a single dose. The blood will be used to measure&#xD;
      the numbers of different types of stem cells, to evaluate potential effects of stem cell&#xD;
      mobilization and homing after consuming plant-based extracts. Adult stem cells are a type of&#xD;
      cells that play a role in repairing and rejuvenating various tissue and organs in the body.&#xD;
      At NIS Labs, we have shown that many types of plant-based nutritional products have small but&#xD;
      reproducible and significant effects on stem cells, cytokines, and regenerative growth&#xD;
      factors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Anticipated">February 2, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The study uses a randomized double-blinded placebo-controlled cross-over study design.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Both the study participants and the research staff interacting with study participants will be blinded to the plant based extract versus placebo.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change to stem cell numbers in blood circulation.</measure>
    <time_frame>Changes at 1 and 2 hours after consumption.</time_frame>
    <description>Flow cytometry evaluation of stem cell phenotype.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change to numbers of circulating CD45dim CD34+ stem cells in blood circulation.</measure>
    <time_frame>Changes at 1 and 2 hours after consumption.</time_frame>
    <description>Flow cytometry evaluation of stem cell phenotype.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change to numbers of circulating CD45dim CD34+ CD309- stem cells in blood circulation.</measure>
    <time_frame>Changes at 1 and 2 hours after consumption.</time_frame>
    <description>Flow cytometry evaluation of stem cell phenotype.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change to numbers of circulating CD45dim CD34+ CD309+ stem cells in blood circulation.</measure>
    <time_frame>Changes at 1 and 2 hours after consumption.</time_frame>
    <description>Flow cytometry evaluation of stem cell phenotype.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change to numbers of circulating CD45- CD31+ CD309+ stem cells in blood circulation.</measure>
    <time_frame>Changes at 1 and 2 hours after consumption.</time_frame>
    <description>Flow cytometry evaluation of stem cell phenotype.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change to numbers of circulating CD45- CD90+ stem cells in blood circulation.</measure>
    <time_frame>Changes at 1 and 2 hours after consumption.</time_frame>
    <description>Flow cytometry evaluation of stem cell phenotype.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Stem Cell Mobilization</condition>
  <condition>Hematopoietic Stem Cell Mobilization</condition>
  <condition>Stem Cell Homing</condition>
  <arm_group>
    <arm_group_label>Berry extract I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plant-based antioxidant-rich berry-based extract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Berry extract II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Plant-based antioxidant-rich berry-based extract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Berry extract blend</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blend of plant-based antioxidant-rich berry-based extracts.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Berry extract I</intervention_name>
    <description>Seabuckthorn berry proanthocyanidin extract 250 mg single dose</description>
    <arm_group_label>Berry extract I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Berry Extract II</intervention_name>
    <description>Seabuckthorn berry proanthocyanidin extract 500 mg single dose</description>
    <arm_group_label>Berry extract II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Berry extract blend</intervention_name>
    <description>Seabuckthorn berry blend with other berry-based antioxidants</description>
    <arm_group_label>Berry extract blend</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy adults 20-75 years of age;&#xD;
&#xD;
          -  Body weight higher than 110 pounds;&#xD;
&#xD;
          -  BMI below 35;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous major gastrointestinal surgery (absorption of test product may be altered)&#xD;
             (minor surgery not a problem);&#xD;
&#xD;
          -  Currently taking daily OTC medications, such as NSAIDs, Tylenol, allergy medications,&#xD;
             and others (birth control and 81 mg aspirin not a problem);&#xD;
&#xD;
          -  Taking medications that affect the mind (such as anti-depressants) or nervous system&#xD;
             (such as gabapentin);&#xD;
&#xD;
          -  Currently experiencing intense stressful events and life changes;&#xD;
&#xD;
          -  Actively depressed;&#xD;
&#xD;
          -  Experiencing sleep disturbances;&#xD;
&#xD;
          -  Working night shift;&#xD;
&#xD;
          -  Pregnant, nursing, or trying to become pregnant;&#xD;
&#xD;
          -  Food intolerances or allergies currently causing discomfort (such as Celiac's&#xD;
             disease), due to ongoing inflammatory reactions that may negatively affect product&#xD;
             absorption within the 3 hours of testing;&#xD;
&#xD;
          -  Food allergies related to ingredients in test product.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gitte Jensen</last_name>
    <role>Study Director</role>
    <affiliation>NIS Labs</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gitte Jensen</last_name>
    <phone>5418840112</phone>
    <email>gitte@nislabs.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Natural Immune Systems</name>
      <address>
        <city>Klamath Falls</city>
        <state>Oregon</state>
        <zip>97601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gitte Jensen</last_name>
      <phone>541-884-0112</phone>
      <email>gitte@nislabs.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>December 23, 2017</study_first_submitted>
  <study_first_submitted_qc>December 29, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 2, 2018</study_first_posted>
  <last_update_submitted>March 11, 2019</last_update_submitted>
  <last_update_submitted_qc>March 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

